Sina Jasim

Medicine & Life Sciences

1. Thyroid Neoplasms 100%
2. Systematic Reviews 82%
3. Meta-Analysis 77%
4. Paraganglioma 75%
5. Pheochromocytoma 68%
6. Cancer Survivors 64%
7. Thyroid Gland 64%
8. Growth Hormone 56%
9. Endocrinologists 55%
10. Adrenocortical Carcinoma 53%
11. Hypopituitarism 50%
12. Parathyroidectomy 49%
13. Thyroid Nodule 49%
14. Primary Hyperparathyroidism 47%
15. Endocrinology 46%
16. Neoplasms 37%
17. Multiple Endocrine Neoplasia Type 2b 31%
18. Iodine 30%
19. Therapeutics 29%
20. Osteosclerosis 29%
21. Medullary Thyroid cancer 29%
22. pazopanib 29%
23. lenvatinib 27%
24. alpha-Methyltyrosine 27%
25. Lipid A 26%
26. Off-Label Use 26%
27. Fine Needle Biopsy 25%
28. Insulin-Like Growth Factor Binding Protein 3 24%
29. Confidence Intervals 23%
30. Proto-Oncogenes 23%
31. Thyroid Hormones 22%
32. Watchful Waiting 22%
33. Goiter 22%
34. Practice Guidelines 22%
35. Bone Diseases 22%
36. Pituitary Neoplasms 21%
37. Muscular Diseases 21%
38. Quality of Life 21%
39. Local Anesthetics 20%
40. Insulin-Like Growth Factor I 19%
41. Checklist 19%
42. Databases 17%
43. Radiotherapy 17%
44. Recurrence 17%
45. Testosterone 17%
46. Tertiary Care Centers 17%
47. Survivors 17%
48. Guidelines 16%
49. Thyroid Diseases 16%
50. Lymphoma 16%